Synthesis, antiproliferative and antimicrobial activities of (KLAKLAK)₂-NH₂ analogue containing nor-Leu and its conjugates with a second pharmacophore

References

• He YM, Feng L, Huo DM, et al. Enalapril versus losartan for adults with chronic kidney disease: a systematic review and meta-analysis. Nephrology (Carlton). 2013;18(9):605–614.
   PubMed Web of Science ®Google Scholar
• Grandjean EM, Berthet P, Ruffmann R, et al. Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials. Clin Ther. 2000;22(2):209–221.
   PubMed Web of Science ®Google Scholar
• Sadowska AM, Verbraecken J, Darquennes K, et al. Role of N-acetylcysteine in the management of COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(4):425–434.
   PubMedGoogle Scholar
• Zintel HA, Ma RA, Nichols AC, et al. The absorption, distribution, excretion and toxicity of bacitracin in man. Am J Med Sci. 1949;218(4):439–445.
   PubMed Web of Science ®Google Scholar
• Johnson BA, Anker H, Meleney FL. Bacitracin: a new antibiotic produced by a member of the B. subtilis group. Science. 1945;102(2650):376–377.
   PubMed Web of Science ®Google Scholar
• Wang F, Qin L, Pace CJ, et al. Solubilized gramicidin A as potential systemic antibiotics. ChemBioChem. 2012;13(1):51–55.
   PubMed Web of Science ®Google Scholar
• Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discov Today. 2015;20(1):122–128.
   PubMed Web of Science ®Google Scholar
• Pyronnet S, Bousquet C, Najib S, et al. Antitumor effect of somatostatin. Mol Cell Endocrinol. 2008;286(1-2):230–237.
   PubMed Web of Science ®Google Scholar
• Appetecchia M, Baldelli R. Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives. J Exp Clin Cancer Res. 2010;29(1):1–19.
   PubMedGoogle Scholar
• Pollak M. The potential role of somatostatin analogues in breast cancer treatment. Yale J Biol Med. 1997;70(5-6):535–539.
   PubMed Web of Science ®Google Scholar
• Strosberg J, Kvols L. Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors. World J Gastroenterol. 2010;16(24):2963–2970.
   PubMed Web of Science ®Google Scholar
• Paz-Bouza JI, Redding TW, Schally AV. Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone. Proc Natl Acad Sci USA. 1987;84(4):1112–1116.
   PubMed Web of Science ®Google Scholar
• Rose DP, Gottardis M, Noonan JJ. Rat mammary carcinoma regressions during suppression of serum growth hormone and prolactin. Anticancer Res. 1983;3(5):323–325.
   PubMed Web of Science ®Google Scholar
• Schally AV, Comaru-Schally AM, Redding TW. Antitumor effects of analogs of hypothalamic hormones in endocrine-dependent cancers. Proc Soc Exp Biol Med. 1984;175(3):259–281.
   PubMed Web of Science ®Google Scholar
• Schally AV, Redding TW, Comaru-Schally AM. Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms. Cancer Treat Rep. 1984;68(1):281–289.
   PubMedGoogle Scholar
• Zalatnai A, Paz-Bouza JI, Redding TW, et al. Histologic changes in the rat prostate cancer model after treatment with somatostatin analogs and D-Trp-6-LH-RH. Prostate. 1988;12(1):85–98.
   PubMed Web of Science ®Google Scholar
• Farkhani SM, Valizadeh A, Karami H, et al. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules. Peptides. 2014;57:78–94.
   PubMed Web of Science ®Google Scholar
• Bian J, Popović ZB, Benejam C, et al. Effect of cell-based intercellular delivery of transcription factor GATA4 on ischemic cardiomyopathy. Circ Res. 2007;100(11):1626–1633.
   PubMed Web of Science ®Google Scholar
• Fawell S, Seery J, Daikh Y, et al. Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA. 1994;91(2):664–668.
   PubMed Web of Science ®Google Scholar
• Rousselle C, Clair P, Lefauconnier JM, et al. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. Mol Pharmacol. 2000;57(4):679–686.
   PubMed Web of Science ®Google Scholar
• Muratovska A, Eccles MR. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett. 2004;558(1-3):63–68.
   PubMed Web of Science ®Google Scholar
• Sebbage V. Cell-penetrating peptides and their therapeutic applications. Biosci Horiz. 2009;2(1):64–72.
   Google Scholar
• Habault J, Poyet J-L. Recent advances in cell penetrating peptide-based anticancer therapies. Molecules. 2019;24(5):927.
   PubMed Web of Science ®Google Scholar
• Jaber S, Iliev I, Angelova T, et al. Synthesis, antitumor and antibacterial studies of new shortened analogues of (KLAKLAK)2-NH2 and their conjugates containing unnatural amino acids. Molecules. 2021;26(4):898.
   PubMed Web of Science ®Google Scholar
• Jaber S, Nemska V, Iliev I, et al. Synthesis and biological studies on (KLAKLAK)2-NH2 analog containing unnatural amino acid β-Ala and conjugates with second pharmacophore. Molecules. 2021;26(23):7321.
   PubMed Web of Science ®Google Scholar
• Marinov MN, Naydenova ED, Momekov GT, et al. Synthesis, characterization, quantum-chemical calculations and cytotoxic activity of 1,8-naphthalimide derivatives with non-protein amino acids. Anticancer Agents Med Chem. 2019;19(10):1276–1284.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55–63.
   PubMed Web of Science ®Google Scholar
• Cabrele C, Martinek TA, Reiser O, et al. Peptides containing β‑amino acid patterns: challenges and successes in medicinal chemistry. J Med Chem. 2014;57(23):9718–−9739. 10.1021/jm5010896.
   PubMed Web of Science ®Google Scholar
• Chayrov R, Parisis N, Chatziathanasiadou M, et al. Synthetic analogues of aminoadamantane as influenza viral inhibitors-in vitro, in silico and QSAR studies. Molecules. 2020;25(17):3989.
   PubMed Web of Science ®Google Scholar
• Pejin B, Iodice C, Tommonaro G, et al. Further in vitro evaluation of cytotoxicity of the marine natural product derivative 4′-leucine-avarone. Nat Prod Res. 2014;28(5):347–350.
   PubMed Web of Science ®Google Scholar
• Sathuvan M, Thangam R, Gajendiran M, et al. κ-Carrageenan: an effective drug carrier to deliver curcumin in cancer cells and to induce apoptosis. Carbohydr Polym. 2017;160:184–193.
   PubMed Web of Science ®Google Scholar
• Tsekova P, Spasova M, Manolova N, et al. Еlectrospun сellulose acetate membranes decorated with curcumin-PVP particles: preparation, antibacterial and antitumor activities. J Mater Sci Mater Med. 2017;29(1):9.
   PubMed Web of Science ®Google Scholar
• Rosendahl AH, Perks CM, Zeng L, et al. Caffeine and caffeic acid inhibit growth and modify estrogen receptor and insulin-like growth factor I receptor levels in human breast cancer. Clin Cancer Res. 2015;21(8):1877–1887.
   PubMed Web of Science ®Google Scholar
• Chung T-W, Moon S-K, Chang Y-C, et al. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dualmechanism. FASEB J. 2004;18(14):1670–1681.
   PubMed Web of Science ®Google Scholar
• Chang W-C, Hsieh C-H, Hsiao M-W, et al. Caffeic acid induces apoptosis in human cervical cancer cells through the mitochondrial pathway. Taiwan J Obstet Gynecol. 2010;49(4):419–424.
   PubMed Web of Science ®Google Scholar
• Prasad NR, Karthikeyan A, Karthikeyan S, et al. Inhibitory effect of caffeic acid on cancer cell proliferation by oxidative mechanism in human HT-1080 fibrosarcoma cell line. Mol Cell Biochem. 2011;349(1-2):11–19.
   PubMed Web of Science ®Google Scholar
• Murad LD, Soares NCP, Brand C, et al. Effects of caffeic and 5-caffeoylquinic acids on cell viability and cellular uptake in human colon adenocarcinoma cells. Nutr Cancer. 2015;67(3):532–542.
   PubMed Web of Science ®Google Scholar
• Ignatova MG, Manolova NE, Rashkov IB, et al. Poly(3-hydroxybutyrate)/caffeic acid electrospun fibrous materials coated with polyelectrolyte complex and their antibacterial activity and in vitro antitumor effect against HeLa cells. Mater Sci Eng C Mater Biol Appl. 2016;65:379–392.
   PubMed Web of Science ®Google Scholar
• Braña MF, Ramos A. Naphthalimides as anticancer agents: synthesis and biological activity. Curr Med Chem Anticancer Agents. 2001;1(3):237–255.
   PubMedGoogle Scholar
• Banerjee S, Veale EB, Phelan CM, et al. Recent advances in the development of 1,8-naphthalimide based DNA targeting binders, anticancer and fluorescent cellular imaging agents. Chem Soc Rev. 2013;42(4):1601–1618.
   PubMed Web of Science ®Google Scholar
• Kamal A, Bolla NR, Srikanth PS, et al. Naphthalimide derivatives with therapeutic characteristics: a patent review. Expert Opin Ther Pat. 2013;23(3):299–317.
   PubMed Web of Science ®Google Scholar
• Wang K-R, Qian F, Wang X-M, et al. Cytotoxic activity and DNA binding of naphthalimide derivatives with amino acid and dichloroacetamide functionalizations. Chin Chem Lett. 2014;25(7):1087–1093.
   Web of Science ®Google Scholar
• Braña MF, Castellano JM, Jiménez A, et al. Synthesis, cytostatic activity and mode of action of a new series of imide derivatives of 3-nitro-11α naphtalic acid. Curr Chemother. 1978;2:1216–1217.
   Google Scholar
• Braña MF, Castellano JM, Roldán CM, et al. Synthesis and mode(s) of action of a new series of imide derivatives of 3-nitro-1,8-naphthalic acid. Cancer Chemother Pharmacol. 1980;4(1):61–66.
   PubMed Web of Science ®Google Scholar